ERICA LEE: Open Payments
NPI 1902342322 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,638 in 66 payments from 7 companies in 2025. Trend: 2023 $1,411 · 2024 $1,788 · 2025 $1,638
Food & beverage: $1,638
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 19 | $489 |
| Otsuka America Pharmaceutical, Inc. | 11 | $326 |
| E.R. Squibb & Sons, L.L.C. | 10 | $280 |
| Alkermes, Inc. | 12 | $246 |
| Lundbeck LLC | 8 | $162 |
| Janssen Pharmaceuticals, Inc | 4 | $91 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
Products named: INGREZZA, ABILIFY ASIMTUFII, COBENFY, ARISTADA, ABILIFY MAINTENA, INVEGA SUSTENNA, UZEDY, SPRAVATO.
Industry payments across LA — which companies pay providers there.
